CALCULATION OF SOLVATION AND BINDING FREE-ENERGY DIFFERENCES BETWEEN VX-478 AND ITS ANALOGS BY FREE-ENERGY PERTURBATION AND AMSOL METHODS

VX-478 belongs to a novel class of HIV-1 protease inhibitors that are based on N,N-disubstituted benzene sulfonamides. Force field parameter s for the N,N-dialkyl benzene sulfonamide moiety have been assembled f rom the literature and from our own ab initio calculations. These para meters were employed to calculate solvation and binding free energy di fferences between VX-478 and two analogs. The free energy perturbation method has been used to determine these differences using two approac hes. In the first approach, intergroup interaction terms only were inc luded in the calculation of free energies (as in most reports of free energy calculations using AMBER). In the second approach, both the int er- and intragroup interaction terms were included. The results obtain ed with the two approaches are in excellent agreement with each other and are also in close agreement with the experimental results. The sol vation free energies of N,N-dimethyl benzene sulfonamide derivatives ( truncated models of the inhibitors), calculated using continuum solvat ion (AMSOL) methods, are found to be in qualitative agreement with the experimental and free energy perturbation results. The binding and so lvation free energy results are discussed in the context of structure- based drug design to show how physicochemical properties (for example aqueous solubilities and bioavailabilities) of these HIV-1 protease in hibitors were improved, while maintaining their inhibitory potency.